Qingyuan Zhao1, Yang Chen2, Jingshu Wang1, Dylan S Small1. 1. Department of Statistics, Wharton School, University of Pennsylvania, Philadelphia, PA, USA. 2. Department of Statistics, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Summary-data Mendelian randomization (MR) has become a popular research design to estimate the causal effect of risk exposures. With the sample size of GWAS continuing to increase, it is now possible to use genetic instruments that are only weakly associated with the exposure. DEVELOPMENT: We propose a three-sample genome-wide design where typically 1000 independent genetic instruments across the whole genome are used. We develop an empirical partially Bayes statistical analysis approach where instruments are weighted according to their strength; thus weak instruments bring less variation to the estimator. The estimator is highly efficient with many weak genetic instruments and is robust to balanced and/or sparse pleiotropy. APPLICATION: We apply our method to estimate the causal effect of body mass index (BMI) and major blood lipids on cardiovascular disease outcomes, and obtain substantially shorter confidence intervals (CIs). In particular, the estimated causal odds ratio of BMI on ischaemic stroke is 1.19 (95% CI: 1.07-1.32, P-value <0.001); the estimated causal odds ratio of high-density lipoprotein cholesterol (HDL-C) on coronary artery disease (CAD) is 0.78 (95% CI: 0.73-0.84, P-value <0.001). However, the estimated effect of HDL-C attenuates and become statistically non-significant when we only use strong instruments. CONCLUSIONS: A genome-wide design can greatly improve the statistical power of MR studies. Robust statistical methods may alleviate but not solve the problem of horizontal pleiotropy. Our empirical results suggest that the relationship between HDL-C and CAD is heterogeneous, and it may be too soon to completely dismiss the HDL hypothesis.
BACKGROUND: Summary-data Mendelian randomization (MR) has become a popular research design to estimate the causal effect of risk exposures. With the sample size of GWAS continuing to increase, it is now possible to use genetic instruments that are only weakly associated with the exposure. DEVELOPMENT: We propose a three-sample genome-wide design where typically 1000 independent genetic instruments across the whole genome are used. We develop an empirical partially Bayes statistical analysis approach where instruments are weighted according to their strength; thus weak instruments bring less variation to the estimator. The estimator is highly efficient with many weak genetic instruments and is robust to balanced and/or sparse pleiotropy. APPLICATION: We apply our method to estimate the causal effect of body mass index (BMI) and major blood lipids on cardiovascular disease outcomes, and obtain substantially shorter confidence intervals (CIs). In particular, the estimated causal odds ratio of BMI on ischaemic stroke is 1.19 (95% CI: 1.07-1.32, P-value <0.001); the estimated causal odds ratio of high-density lipoprotein cholesterol (HDL-C) on coronary artery disease (CAD) is 0.78 (95% CI: 0.73-0.84, P-value <0.001). However, the estimated effect of HDL-C attenuates and become statistically non-significant when we only use strong instruments. CONCLUSIONS: A genome-wide design can greatly improve the statistical power of MR studies. Robust statistical methods may alleviate but not solve the problem of horizontal pleiotropy. Our empirical results suggest that the relationship between HDL-C and CAD is heterogeneous, and it may be too soon to completely dismiss the HDL hypothesis.
Authors: Linda Kachuri; Soyoung Jeon; Andrew T DeWan; Catherine Metayer; Xiaomei Ma; John S Witte; Charleston W K Chiang; Joseph L Wiemels; Adam J de Smith Journal: Am J Hum Genet Date: 2021-08-31 Impact factor: 11.043
Authors: Matthew T Patrick; Philip E Stuart; Haihan Zhang; Qingyuan Zhao; Xianyong Yin; Kevin He; Xu-Jie Zhou; Nehal N Mehta; John J Voorhees; Michael Boehnke; Johann E Gudjonsson; Rajan P Nair; Samuel K Handelman; James T Elder; Dajiang J Liu; Lam C Tsoi Journal: J Invest Dermatol Date: 2020-12-30 Impact factor: 7.590
Authors: Stephen Burgess; George Davey Smith; Neil M Davies; Frank Dudbridge; Dipender Gill; M Maria Glymour; Fernando P Hartwig; Michael V Holmes; Cosetta Minelli; Caroline L Relton; Evropi Theodoratou Journal: Wellcome Open Res Date: 2020-04-28